P781: EVALUATION OF PEGCETACOPLAN TREATMENT SUCCESS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH AND WITHOUT BONE MARROW FAILURE: A MOVE TOWARDS INDIVIDUALIZED PATIENT TREATMENT

• Jeff Szer,
• Jens Panse,
• Austin Kulasekararaj,
• Monika Oliver,
• Bruno Fattizzo,
• Jun-Ichi Nishimura,
• Johan Szamosi,
• Regina Horneff,
• Régis Peffault de Latour

Affiliations

Jeff Szer

1 Peter MacCallum Cancer Centre & Royal Melbourne Hospital Australia, Department of Clinical Haematology, Melbourne, Australia

Jens Panse

2 University Hospital RWTH Aachen, Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation; Centre for Integrated Oncology (CIO), Aachen, Germany

Austin Kulasekararaj

3 King’s College Hospital, National Institute of Health Research/Wellcome King’s Clinical Research Facility, Department of Haematological Medicine, London, United Kingdom

Monika Oliver

4 University of Alberta Hospital, Hemtatology & Apheresis Medicine, Edmonton, Canada

Bruno Fattizzo

5 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico; University of Milan, Hematology Unit; Department of Oncology and Hemato-Oncology, Milan, Italy

Jun-Ichi Nishimura

6 Osaka University Graduate School of Medicine, Department of Haematology and Oncology, Osaka, Japan

Johan Szamosi

7 Sobi Sweden, Stockholm, Sweden

Regina Horneff

7 Sobi Sweden, Stockholm, Sweden

Régis Peffault de Latour

8 French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France